Product image of Irbesartan Stada (Irbesartan) supplied by GNH India

Irbesartan Stada

Active Ingredient:
Irbesartan
Origin:
EU

Irbesartan Stada (Irbesartan)

Irbesartan, the active ingredient in Irbesartan Stada, is a Angiotensin II receptor blocker (ARB) presented as a tablet for oral use. It treats hypertension and diabetic nephropathy in adult patients.

GNH India supplies Irbesartan Stada as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Stada Lda.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Irbesartan belongs to the ARB class and is used to manage conditions related to the renin‑angiotensin system.

  • Hypertension: lowers elevated blood pressure and reduces cardiovascular risk.
  • Diabetic nephropathy: slows the progression of kidney damage in patients with type 2 diabetes.
  • Proteinuria associated with diabetes: reduces urinary protein excretion, indicating renal protection.

How It Works

  • Irbesartan selectively blocks the angiotensin II type 1 (AT1) receptor, preventing angiotensin II‑mediated vasoconstriction and aldosterone release. This inhibition leads to relaxation of vascular smooth muscle, reduced peripheral resistance, and decreased sodium and water retention, thereby lowering blood pressure and providing renal protective effects.

Side Effects

Common Side Effects

  • Dizziness: sensation of light‑headedness, especially after standing.
  • Headache: mild to moderate intensity.
  • Fatigue: general feeling of tiredness.
  • Nasal congestion: blocked or runny nose.
  • Back pain: discomfort in the lumbar region.

Serious or Rare Side Effects

  • Angioedema: swelling of face, lips, tongue, or throat that may compromise breathing.
  • Severe hyperkalaemia: markedly elevated blood potassium levels.
  • Acute renal impairment: sudden decline in kidney function.
  • Hepatic injury: abnormal liver enzyme elevations.
  • Anaphylactic reaction: severe allergic response requiring immediate medical attention.

Precautions & Warnings

Before initiating therapy, clinicians should assess patient-specific factors and monitor relevant parameters.

  • Blood pressure monitoring: ensure target levels are achieved without excessive drop.
  • Renal function assessment: check serum creatinine and eGFR regularly.
  • Serum potassium evaluation: monitor for hyperkalaemia, especially with concomitant potassium‑sparing agents.
  • Hepatic impairment caution: adjust use in patients with liver disease.
  • Pregnancy avoidance: discontinue if pregnancy is confirmed or planned.
  • Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Avoid Interactions

Irbesartan may interact with several medicines; careful review is required.

Major Interactions (Avoid)

  • Aliskiren (in diabetic patients): combined use can increase renal risk.
  • ACE inhibitors or other ARBs: concurrent therapy may cause excessive potassium rise and kidney injury.
  • Potassium supplements or potassium‑sparing diuretics: risk of hyperkalaemia.

Moderate Interactions (Monitor Closely)

  • NSAIDs: may attenuate antihypertensive effect and affect renal function.
  • Lithium: irbesartan can increase lithium concentrations, requiring serum level monitoring.

Frequently Asked Questions

Irbesartan Stada is prescribed to lower high blood pressure (hypertension) and to protect kidney function in adults with diabetic nephropathy. By managing these conditions, it helps reduce the risk of cardiovascular events and slows the progression of kidney disease associated with diabetes.

Irbesartan blocks the angiotensin II type 1 (AT1) receptor, which prevents the hormone angiotensin II from causing blood vessels to narrow and from stimulating aldosterone release. This results in vasodilation, reduced fluid retention, and lower blood pressure, while also offering renal protective effects.

The appropriate dose of Irbesartan Stada is determined by the prescribing healthcare professional based on the individual’s medical condition, response to therapy, and other factors. Patients should follow the exact dosage instructions provided by their prescriber and not adjust the dose on their own.

Irbesartan Stada is generally not recommended during pregnancy because it may harm the developing fetus. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss alternative treatments with their healthcare provider.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Irbesartan belongs to the ARB class, which offers blood‑pressure control similar to ACE inhibitors but with a lower incidence of cough and angioedema. Compared with calcium‑channel blockers or diuretics, ARBs target the renin‑angiotensin system directly, providing additional renal protection in diabetic patients.

Irbesartan Stada should be stored at room temperature, below 25 °C, in its original packaging. Keep the product away from moisture, direct sunlight, and extreme temperatures to maintain its stability and potency.

Irbesartan Stada is taken orally, usually once daily, with or without food. The tablet should be swallowed whole with a glass of water. Patients should follow the dosing schedule prescribed by their healthcare professional.

Serious risks include angioedema, severe hyperkalaemia, and acute kidney injury. Patients should seek immediate medical attention if they experience swelling of the face or throat, sudden weakness, or a marked increase in blood potassium levels.

Irbesartan Stada should be avoided in individuals with known hypersensitivity to irbesartan or any component of the formulation, in patients with severe hepatic impairment, and in women who are pregnant. It should also be used with caution in those with existing kidney disease or elevated potassium levels.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Irbesartan

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT